AbCellera Biologics Inc. (NASDAQ:ABCL) Q3 2024 Earnings Call Transcript

AbCellera Biologics Inc. (NASDAQ:ABCL) Q3 2024 Earnings Call Transcript November 4, 2024

AbCellera Biologics Inc. misses on earnings expectations. Reported EPS is $-0.17 EPS, expectations were $-0.15.

Operator: Good afternoon, and welcome to AbCellera’s Q3 2024 Business Update Conference Call. My name is Tamiya, and I will facilitate the audio portion of today’s interactive broadcast. [Operator Instructions] At this time, I would now like to turn the call over to Tryn Stimart, AbCellera’s...